Harness Trainer Christopher Oakes Sentenced To 3 Years In Federal Doping Case

Oakes’s Sentence Caps a Month of Convictions and Sentences in Ongoing Doping Investigations

Damian Williams, the United States Attorney for the Southern District of New York, announced that defendant CHRISTOPHER OAKES received a sentence of thirty-six months in prison today for his role in the felony drug misbranding and adulteration charges arising from this Office’s investigation of the abuse of animals through the use of performance enhancing drugs and as charged in United States v. Navarro et al., 20 Cr. 160 (MKV). OAKES’s sentence followed the February 24, 2022, sentencing of thoroughbred trainer MARCOS ZULUETA to a term of thirty-three months in prison, and the guilty plea of harness trainer RICK DANE, JR., on February 18, 2022. OAKES and ZULUETA were each sentenced by U.S. District Judge Mary Kay Vyskocil, who will preside over the sentencing of DANE on June 21, 2022.

 

FDA Commits To Compounding Drug Rulemaking - Law360

https://www.law360.com › articles › fda-commits-to-com...

6 days ago — and five other pharmacies that make compound drugs

 

Two-Decade Old US Interstate Compounding Provision ...

https://pink.pharmaintelligence.informa.com › Two-Deca...

2 days ago — Responding to court ruling, US FDA will explore

Great Article in STAT Pharmalot about a Compounding Pharmacy Who Recalled All Its Products

Here

 

03/01/2022	03/01/2022	CT Vapors	Center for Tobacco Products	Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
03/01/2022	03/01/2022	Synergy Mixing Labs, LLC	Center for Tobacco Products	Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
03/01/2022	03/01/2022	E-Cig USA Inc d/b/a Hutchinson Tobacco and Cigar	Center for Tobacco Products	Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
03/01/2022	11/03/2021	Rainfield Marketing Group, Inc.	Division of West Coast Imports	Foreign Supplier Verification Program (FSVP)
03/01/2022	01/24/2022	Greenhead Lobster Products LLC	Office of Human and Animal Food Operations- East Division 1	Seafood HACCP/CGMP for Foods/Adulterated/Insanitary Conditions
03/01/2022	02/11/2022	Cedar’s Mediterranean Foods Inc.	Office of Human and Animal Food Operations East – Division 1	Food Labeling/Misbranded
03/01/2022	02/18/2022	Wild Vapers LLC	Center for Tobacco Products	Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
03/01/2022	02/17/2022	Vital Health & Wellness	Office of Human and Animal Foods Operations-East V	New Drug/Misbranded

 

Press release: FDA concedes in compounding MOU case - APC

https://a4pc.org › press-release-fda-concedes-in-compo...

1 day ago — Azar, brought in federal court against the agency in 2020 by seven compounding pharmacies. The Alliance for Pharmacy Compounding was party to an amicus filing ...

 

Serious Adverse effects From Compounding Errors With Low ...

https://www.actasdermo.org › es-serious-adverse-effects...

13 hours ago — Serious Adverse effects From Compounding Errors With Low-Dose Oral Minoxidil for Alopecia Treatment. “Efectos adversos graves por errores de formulación de ...

FDA to redo key compounding pharmacy policy in win for industry By Nate Raymond FDA plans to go through formal rule making process to redo and implement the MOU. Will not enforce 5% rule in meantime. But the federal legislation with the 5% cap is still the law on the books passed by Congress.

 

https://www.reuters.com/legal/litigation/fda-redo-key-compounding-pharmacy-policy-win-industry-2022-02-23/

 

Reader disagrees with Griffith's facts on health care bills | Letters

https://swvatoday.com › opinion › letters

3 hours ago — ... of medical production information, expanding access to compounded medications and reducing barriers to the research of cannabis and Schedule I drugs.”

 

COVID-19 Sparks Compounded Drug Concerns - US ...

https://www.uspharmacist.com › article › covid19-spark...

7 hours ago — A product report reference was utilized to determine which facilities compounded drugs for hospitalized patients with COVID-19. The agency drafted new guidance ...